A Case Report of a Novel Myelin Protein Zero (

Lu Xia, Liyan Cai, Xin Chen, Kun Zhou, Wei Huang, Yuanyuan Zhu, Shinian Yang

Abstract read

In one paragraph

Article in Case reports in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lu XiaDepartment of Rehabilitation, Chengdu First People's Hospital, Chengdu Sichuan, 610041, China, scu.edu.cn.ORCID https://orcid.org/0000-0002-2264-4793

Liyan CaiDepartment of Rehabilitation, Chengdu First People's Hospital, Chengdu Sichuan, 610041, China, scu.edu.cn.

Xin ChenDepartment of Rehabilitation, Chengdu First People's Hospital, Chengdu Sichuan, 610041, China, scu.edu.cn.ORCID https://orcid.org/0009-0007-7479-9766

Kun ZhouDepartment of Rehabilitation, Chengdu First People's Hospital, Chengdu Sichuan, 610041, China, scu.edu.cn.ORCID https://orcid.org/0009-0003-1544-7382

Wei HuangDepartment of Neurology, Chengdu First People's Hospital, Chengdu Sichuan, 610041, China, scu.edu.cn.ORCID https://orcid.org/0009-0001-4249-1667

Yuanyuan ZhuDepartment of Rehabilitation, Chengdu First People's Hospital, Chengdu Sichuan, 610041, China, scu.edu.cn.ORCID https://orcid.org/0009-0003-6297-5137

Shinian YangDepartment of Rehabilitation, Chengdu First People's Hospital, Chengdu Sichuan, 610041, China, scu.edu.cn.ORCID https://orcid.org/0009-0006-9249-9022

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Charcot-Marie-Tooth (CMT) disease is the collective term for the most common inherited peripheral neuropathies, affecting both motor and sensory nerves. A typical CMT patient presents with slowly progressive distal muscle weakness and atrophy that primarily involves the small foot muscles, peroneal muscles, and, often later, the muscles of the hands and forearms. Foot deformities, most commonly pes cavus and claw toes, are common and can lead to gait impairments. In this paper, we report a patient with an intermediate CMT (CMT-Int) type carrying a novel pathogenic variant in the

Indexed as

Charcot–Marie–tooth diseaseMPZ gene mutationmyelin protein zerotype 2 diabetes

Identifiers

PMID42732363

DOI10.1155/crig/8838487

PMCPMC13570443

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.